IANNONE, LUIGI FRANCESCO
IANNONE, LUIGI FRANCESCO
Scienze della Salute (DSS)
Emerging Pharmacological Treatments for Migraine in the Pediatric Population
2022 Iannone L.F.; De Cesaris F.; Geppetti P.
The role of TRP ion channels in migraine and headache
2022 Iannone L.F.; De Logu F.; Geppetti P.; De Cesaris F.
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series
2022 Iannone L.F.; Fattori D.; Geppetti P.; De Cesaris F.
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report
2021 Iannone L.F.; Geppetti P.; Chiarugi A.; De Cesaris F.
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment
2022 Catalano, Martina; Francesco Iannone, Luigi; Cosso, Federica; Generali, Daniele; Mini, Enrico; Roviello, Giandomenico
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
2022 Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F.
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
2022 Iannone, Luigi Francesco; De Cesaris, Francesco; Ferrari, Anita; Benemei, Silvia; Fattori, Davide; Chiarugi, Alberto
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine
2022 Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F.
Current status and future perspectives in HER2 positive advanced gastric cancer
2022 Roviello, G; Catalano, M; Iannone, L F; Marano, L; Brugia, M; Rossi, G; Aprile, G; Antonuzzo, L
The trpa1 channel amplifies the oxidative stress signal in melanoma
2021 De Logu F.; de Araujo D.S.M.; Ugolini F.; Iannone L.F.; Vannucchi M.; Portelli F.; Landini L.; Titiz M.; De Giorgi V.; Geppetti P.; Massi D.; Nassini R.
The gut microbiome and efficacy of cancer immunotherapy
2022 Roviello G.; Iannone L.F.; Bersanelli M.; Mini E.; Catalano M.
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
2021 Roviello G.; Aprile G.; D'Angelo A.; Iannone L.F.; Roviello F.; Polom K.; Mini E.; Catalano M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Emerging Pharmacological Treatments for Migraine in the Pediatric Population | 2022 | Iannone L.F.; De Cesaris F.; Geppetti P. | |
| The role of TRP ion channels in migraine and headache | 2022 | Iannone L.F.; De Logu F.; Geppetti P.; De Cesaris F. | |
| Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series | 2022 | Iannone L.F.; Fattori D.; Geppetti P.; De Cesaris F. | |
| COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report | 2021 | Iannone L.F.; Geppetti P.; Chiarugi A.; De Cesaris F. | |
| Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment | 2022 | Catalano, Martina; Francesco Iannone, Luigi; Cosso, Federica; Generali, Daniele; Mini, Enrico; Roviello, Giandomenico | |
| Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score | 2022 | Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F. | |
| Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine | 2022 | Iannone, Luigi Francesco; De Cesaris, Francesco; Ferrari, Anita; Benemei, Silvia; Fattori, Davide; Chiarugi, Alberto | |
| Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine | 2022 | Iannone L.F.; Fattori D.; Benemei S.; Chiarugi A.; Geppetti P.; De Cesaris F. | |
| Current status and future perspectives in HER2 positive advanced gastric cancer | 2022 | Roviello, G; Catalano, M; Iannone, L F; Marano, L; Brugia, M; Rossi, G; Aprile, G; Antonuzzo, L | |
| The trpa1 channel amplifies the oxidative stress signal in melanoma | 2021 | De Logu F.; de Araujo D.S.M.; Ugolini F.; Iannone L.F.; Vannucchi M.; Portelli F.; Landini L.; Titiz M.; De Giorgi V.; Geppetti P.; Massi D.; Nassini R. | |
| The gut microbiome and efficacy of cancer immunotherapy | 2022 | Roviello G.; Iannone L.F.; Bersanelli M.; Mini E.; Catalano M. | |
| Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? | 2021 | Roviello G.; Aprile G.; D'Angelo A.; Iannone L.F.; Roviello F.; Polom K.; Mini E.; Catalano M. |